Efficacy & Toxicity
Target Validation
Toxicity Assays
Multi Cancer Screening

Jul 15 2021

CLIENT PUBLICATION

 

Learn how professor Michel Lisanti and collaborators integrated Inovotion’s technology into

their study to provide evidence that elevated ATP production by mitochondrial ATP synthase is a

new therapeutic target for cancer treatments, particularly for preventing tumor

progression. https://www.nature.com/articles/s41418-021-00788-x#Abs1

 

If you too are interested in optimizing your preclinical drug discovery with our powerful

in vivo technology platform, please contact us for a free estimate! www.inovotion/contact.com

 

If you wish to discover more example of Inovotion’s client publications in the best peer

reviewed journals please follow the link : https://www.inovotion.com/publications/publications

All our news

All our webinars